BMEA
Biomea Fusion Inc

1,878
Mkt Cap
$96.86M
Volume
1.17M
52W High
$8.28
52W Low
$1.22
PE Ratio
-0.57
BMEA Fundamentals
Price
$1.37
Prev Close
$1.30
Open
$1.27
50D MA
$1.77
Beta
1.20
Avg. Volume
3.44M
EPS (Annual)
-$3.83
P/B
5.22
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Biomea Fusion FY2025 EPS Estimate Lowered by HC Wainwright
Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - HC Wainwright lowered their FY2025 EPS estimates for Biomea Fusion in a research note issued on Wednesday, November 5th. HC Wainwright analyst J...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of "Moderate Buy" by Analysts
Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine brokerages that are covering the stock, MarketBeat.com reports. One...
MarketBeat·1d ago
News Placeholder
Biomea Fusion (NASDAQ:BMEA) Given New $12.00 Price Target at D. Boral Capital
D. Boral Capital dropped their price target on shares of Biomea Fusion from $16.00 to $12.00 and set a "buy" rating on the stock in a research note on Wednesday...
MarketBeat·2d ago
News Placeholder
Biomea Fusion Slides After-Hours Following Stock-And-Warrant Offering; Retail Traders See Rebound Ahead
The offering follows early clinical data from Biomea’s BMF-500 leukemia program, which showed encouraging responses in heavily pretreated patients.
Stocktwits·5mo ago
News Placeholder
Biomea Fusion (BMEA) Upgraded to Buy: Here's What You Should Know
Zacks·5mo ago
News Placeholder
Biomea Fusion's Stock Plummets After Price Target Cut — Bearish Retail Traders Speculate Next Moves
Biomea Fusion is realigning its focus on diabetes and obesity programs, cutting 35% of its workforce and consolidating operations to reduce costs.
Stocktwits·6mo ago
News Placeholder
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate
FDA has lifted the clinical hold on Biomea Fusion's BMF-219 trials for type 1 and type 2 diabetes following a safety review, allowing the ongoing studies to resume. read more...
Benzinga·1y ago
News Placeholder
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
read more...
Benzinga·1y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biomea Fusion, Inc. - BMEA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biomea Fusion, Inc. - BMEA SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biomea Fusion, Inc. - BMEA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biomea Fusion, Inc. - BMEA SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·1y ago

Latest BMEA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.